| [1] |
Paul AC, Anjua J, Ana O, et al. Cervical Cancer[J]. Lancet, 2019,393(10167):169-182.
|
| [2] |
Simms KT, Steinberg J, Caruana M, et al. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study[J]. Lancet Oncol,2019,20(3):394-407.
|
| [3] |
International Agency for Research on Cancer. Human papillomavirus and related diseases in the world[R]. Lyon: IARC,2019.
|
| [4] |
孙可欣，郑荣寿，张思维, 等. 2015年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤,2019,28(1):1-11.
|
| [5] |
Chen W, Molijn A, Enqi W, et al. The variable clinicopathological categories and role of human papillomavirus in cervical adenocarcinoma:a hospital based nation-wide multi-center retrospective study across China[J]. Int J Cancer,2016,139(12):2687-2697.
|
| [6] |
Chen W, Zhang X, Molijn A, et al. Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18[J]. Cancer Cause Control,2009,20(9):1705-1713.
URL
|
| [7] |
Hoppe-Seyler K, Bossler F, Braun JA, et al. The HPV E6/E7 oncogenes: key factors for viral carcinogenesis and therapeutic targets[J]. Trends Microbio,2017,26(2):158-168.
|
| [8] |
Pang CL, Toh SY, He P, et al. A functional interaction o E7 with B-Myb-MuvB complex promotes acute cooperative transcriptional activation of both S- and M-phase genes[J]. Oncogene,2014,33(31):4039-4049.
URL
|
| [9] |
de Freitas AC, Coimbra EC, Leitao MDCG, et al. Molecular targets of HPV oncoproteins: potential biomarkers for cervical carcinogenesis[J]. Biochim Biophys Acta,2014,1845(2):91-103.
|
| [10] |
DeCaprio JA. Human papillomavirus type 16 E7 perturbs DREAM to promote cellular proliferation and mitotic gene expression[J]. Oncogene,2014,33(31):4036-4038.
URL
|
| [11] |
Esterlechner J, Reichert N, Iltzsche F, et al. LIN9, a subunit of the DREAM complex, regulates mitotic gene expression and proliferation of embryonic stem cells[J]. PLoS One,2013,8(5):e62882.
|
| [12] |
Chen HM, Wang J, Zhang YF, et al. Ovarian cancer proliferation and apoptosis are regulated by human transfer RNA methyltransferase 9-likevia LIN9[J]. Oncol Lett,2017,14(4):4461-4466.
|
| [13] |
熊焱强，冯晶，刘朝奇, 等. HPV16E7下调miR-29a促进PC3细胞增殖[J]. 华中科技大学学报(医学版),2018,47(2):145-149.
|
| [14] |
中华预防医学会疫苗与免疫分会. 子宫颈癌等人乳头瘤病毒相关疾病免疫预防专家共识[J]. 中华流行病学杂志,2019,53(8):761-803.
|
| [15] |
Gustinucci D, Giorgi RP, Cesarini E, et al. Use of cytology, E6/E7 mRNA, and p16INK4a-Ki-67 to define the management of human papillomavirus (HPV)-positive women in cervical cancer screening[J]. Am J Clin Pathol,2016,145(1):35-45.
|
| [16] |
Fischer M, Uxa S, Stanko C, et al. Human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway[J]. Sci Rep,2017,7(1):2603.
|
| [17] |
Audra NI, Larisa L. MuvB: A key to cell cycle control in ovarian cancer[J]. Front Oncol,2018,8:223.
|
| [18] |
Muller GA, Stangner K, Schmitt T, et al. Timing of transcription during the cell cycle: protein complexes binding to E2F, E2F/CLE, CDE/CHR, or CHR promoter elements define early and late cell cycle gene expression[J]. Oncotarget,2016,8(58):97736-97748.
|
| [19] |
Nor Rashid N, Yong ZL, Yusof R, et al. HPV 16E7 and 48E7 proteins use different mechanisms to target p130 to overcome cell cycle block[J]. Virol J,2016,13:2.
|
| [20] |
Guiley KZ, Liban TJ, Felthousen JG, et al. Structural Mechanisms of DREAM Complex Assembly and Regulation[J]. Genes Dev,2015,29(9):961-974.
|
| [21] |
Guiley KZ, Iness AN, Saini S, et al. Structural mechanism of Myb-MuvB assembly[J]. Proc Natl Acad Sci USA,2018,115(40):10016-10021.
|
| [22] |
Zhou Z, Flesken-Nikitin A, Corney DC, et al. Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer[J]. Cancer Res,2006,66(16):7889-7898.
|
| [23] |
Gagrica S, Hauser S, Kolfschoten I, et al. Inhibition of oncogenic transformation by mammalian Lin-9, a pRB-associated protein[J]. EMBO J,2004,23(23):4627-4638.
|
| [24] |
Iness AN, Felthousen J, Ananthapadmanabhan V, et al. The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb[J]. Oncogene,2019,38(7):1080-1092.
|
| [25] |
van 't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer[J]. Nature,2002,415(6871): 530-536.
|
| [26] |
Calvisi DF, Simile MM, Ladu S, Frau M, et al. Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53[J]. Hepatology, 2011,53(4):1226-1236.
|